Skip to main content
. 2015 Mar 30;2(1):5–11. doi: 10.1002/ehf2.12025

Figure 1.

Figure 1

The changes in (A) the 6‐min walk distance (6MWD), (B) plasma N‐terminal pro‐brain natriuretic peptide (NT‐proBNP) level, and (C) left ventricular ejection fraction (LVEF) in patients treated with synthetic L‐T3 (liothyronine) or placebo over a period of 6 weeks.